The biotech sector is a hairbreadth away from my sell signal. Any more downside may trigger a substantial sell-off that I estimate may takeIBB down around 10%.
Long-term stocks are still bullish, so should this correction extend to, lets say, the 2000 area for the SPX or to the 101 area for QQQ, there will be a good re-purchase opportunity then.